The Impact of Intraoperative Intravenous Dexamethasone on Postoperative Outcomes in Patients with Diabetes Undergoing Posterior Cervical Decompression and Fusion

Intraoperative intravenous dexamethasone administration during PCDF did not worsen postoperative glycemic control or increase the incidence of wound complications or other adverse outcomes among diabetic patients. Dexamethasone also did not definitively improve postoperative opioid consumption-further research is needed to evaluate this association with greater statistical power.